sur GENEURO SA (EPA:GNRO)
GeNeuro SA: Judicial recovery for its French subsidiary
Biopharmaceutical company GeNeuro SA has announced the opening of receivership proceedings for its French subsidiary, GeNeuro Innovation SAS, following a decision by the Lyon Economic Activities Court. Facing financial difficulties, the subsidiary sought this legal protection. The court appointed SELARL FHBX as receiver.
This restructuring is part of a broader restructuring of the group. On May 27, GeNeuro SA obtained a definitive stay of insolvency proceedings in Switzerland, with no direct impact from the restructuring of its subsidiary. Based in Geneva, GeNeuro focuses on developing treatments for neurodegenerative and autoimmune diseases.
R. E.
Copyright © 2025 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de GENEURO SA